trending Market Intelligence /marketintelligence/en/news-insights/trending/O5Oeeu5a2ddJBMiqScg28Q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

HRA Capital to help raise funds for Nascent Biotech's brain cancer drug

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


HRA Capital to help raise funds for Nascent Biotech's brain cancer drug

Nascent Biotech Inc. has engaged HRA Capital to help raise capital to fund the continual development of Pritumumab, a drug to treat brain cancer, through its phase 1 and phase 2 clinical trials.